These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 20221894

  • 1. Nanochemoprevention by bioactive food components: a perspective.
    Siddiqui IA, Mukhtar H.
    Pharm Res; 2010 Jun; 27(6):1054-60. PubMed ID: 20221894
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.
    Siddiqui IA, Sanna V.
    Mol Nutr Food Res; 2016 Jun; 60(6):1330-41. PubMed ID: 26935239
    [Abstract] [Full Text] [Related]

  • 5. Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention.
    Wang D, Taylor EW, Wang Y, Wan X, Zhang J.
    Int J Nanomedicine; 2012 Jun; 7():1711-21. PubMed ID: 22619522
    [Abstract] [Full Text] [Related]

  • 6. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
    Khan N, Bharali DJ, Adhami VM, Siddiqui IA, Cui H, Shabana SM, Mousa SA, Mukhtar H.
    Carcinogenesis; 2014 Feb; 35(2):415-23. PubMed ID: 24072771
    [Abstract] [Full Text] [Related]

  • 7. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
    Rocha S, Generalov R, Pereira Mdo C, Peres I, Juzenas P, Coelho MA.
    Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
    Granja A, Pinheiro M, Reis S.
    Nutrients; 2016 May 20; 8(5):. PubMed ID: 27213442
    [Abstract] [Full Text] [Related]

  • 14. Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model.
    Xu Q, Yang CH, Liu Q, Jin XF, Xu XT, Tong JL, Xiao SD, Ran ZH.
    J Dig Dis; 2011 Jun 20; 12(3):181-7. PubMed ID: 21615871
    [Abstract] [Full Text] [Related]

  • 15. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
    Carlson JR, Bauer BA, Vincent A, Limburg PJ, Wilson T.
    Mayo Clin Proc; 2007 Jun 20; 82(6):725-32. PubMed ID: 17550753
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of nanotechnology in cancer: emphasis on nanochemoprevention.
    Siddiqui IA, Adhami VM, Chamcheu JC, Mukhtar H.
    Int J Nanomedicine; 2012 Jun 20; 7():591-605. PubMed ID: 22346353
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.
    Cancer Lett; 2007 Jan 08; 245(1-2):232-41. PubMed ID: 16519995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.